Release of our first CSR Report!
We’re excited to announce the publication of our first CSR Report!
HTL Biotechnology’s first symposium at the congress was a resounding success. With a focus on collagen, DNA, and regenerative medicine, we had the opportunity to showcase our cutting-edge technologies, which participants found particularly innovative.
The connections established during the congress promise a bright future for these solutions and reflect growing interest in our expertise.
This first edition confirmed the importance of HTL Biotechnology’s presence at such a prominent event, paving the way for future collaborations and developments.
As a global company, we were delighted to participate in Personal Care and Homecare Ingredients (PCHi) 2025 in Guangzhou, China this year.
HTL Biotechnology made a strong impact this year at IMCAS with a reinforced presence and exciting interactions with our customers and partners.
We’re happy to share that HTL Biotechnology got the new certification ISO 13485.